Hang Lu

Hang Lu
hang.lu@gatech.edu

Hang Lu received her B.S. from the University of Illinois, Urbana-Champaign and her M.S.C.E.P and Ph.D. from the Massachusetts Institute of Technology. She is currently the Associate Dean for Research and Innovation in the College of Engineering and C. J. "Pete" Silas Chair, School of Chemical & Biomolecular Engineering at the Georgia Institute of Technology. Lu's research interests involve the interface of engineering and biology and her lab, the Lu Fluidics Group, is conducting research at these interface levels. The Lu Fluidics Group engineers BioMEMS (Bio Micro-Electro-Mechanical System) and microfluidic devices to address questions in neuroscience, cell biology, and biotechnology that are difficult to answer using conventional techniques.

Faces of Research - Profile Article

Associate Dean for Research and Innovation, College of Engineering
C. J. "Pete" Silas Chair, School of Chemical and Biomolecular Engineering
Phone
404.894.8473
Office
EBB 3017
Additional Research

Microfluidic systems for high-throughput screens and image-based genetics and genomicsSystems biology: large-scale experimentation and data miningMicrotechnologies for optical stimulation and optical recordingBig data, machine vision, automationDevelopmental neurobiology, behavioral neurobiology, systems neuroscienceCancer, immunology, embryonic development, stem cells

IRI and Role
Bioengineering and Bioscience > Faculty
Data Engineering and Science > Affiliated Faculty
Data Engineering and Science
Bioengineering and Bioscience
Artificial Intelligence > ITAB
University, College, and School/Department
Georgia Institute of Technology > College of Engineering > School of Chemical and Biomolecular Engineering

Brooks Lindsey

Brooks Lindsey
brooks.lindsey@bme.gatech.edu

Dr. Lindsey previously developed matrix array transducers, adaptive beamforming strategies, and interventional devices in Stephen Smith’s lab at Duke University, where he received a Ph.D. for his work in 3D transcranial ultrasound.  While at Duke, he was the recipient of a pre-doctoral fellowship from the National Institutes of Health (NIH) as part of the Duke Medical Imaging Training Program.  He also completed postdoctoral training in the labs of Paul Dayton and Xiaoning Jiang at the University of North Carolina and North Carolina State University in contrast-enhanced ultrasound imaging and in the design and fabrication of high frequency, interventional ultrasound transducers.  During this time, he was awarded the Ruth L. Kirschstein National Research Service Award from the NIH to develop endoscopic transducers for contrast-specific imaging in pancreatic cancer.  Dr. Lindsey recently joined the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech-Emory, where he leads the Ultrasonic Imaging and Instrumentation Laboratory.  Dr. Lindsey is an active member of the IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society, the Biomedical Engineering Society and the American Institute of Ultrasound in Medicine and is a member of the Technical Program Committee for the IEEE International Ultrasonics Symposium.  In 2022, Dr. Lindsey received the New Investigator award from the American Institute of Ultrasound in Medicine. At Georgia Tech, Dr. Lindsey holds a primary appointment in Biomedical Engineering.  He is also a faculty member for the Interdisciplinary Bioengineering Graduate Program and holds an adjunct appointment in the School of Electrical and Computer Engineering. Lab members have received best paper, best poster, and best student pitch awards from the IEEE UFFC Society. Research activities in the lab are currently funded by the National Institutes of Health and the National Science Foundation.

Assistant Professor
Phone
404-385-6647
Office
UAW 2107
Additional Research
Dr. Lindsey is interested in developing new imaging technologies for understanding biological processes and for clinical use.In the Ultrasonic Imaging and Instrumentation lab, we develop transducers, contrast agents, and systems for ultrasound imaging and image-guidance of therapy and drug delivery. Our aim is to develop quantitative, functional imaging techniques to better understand the physiological processes underlying diseases, particularly cardiovascular diseases and tumor progression.
IRI and Role
Bioengineering and Bioscience > Faculty
Bioengineering and Bioscience
University, College, and School/Department
Georgia Institute of Technology > College of Engineering > Coulter Department of Biomedical Engineering

Raquel Lieberman

Raquel Lieberman
raquel.lieberman@chemistry.gatech.edu

Raquel Lieberman is the Sepcic-Pfeil Professor of Chemistry & Biochemistry at Georgia Tech. Her research program focuses on biophysical and structural characterization of proteins and the impact of disease-associated mutations on function or dysfunction (e.g. aggregation). Rooted in basic research, the long-term goal of her research program is to convert mechanistic discoveries into disease-modifying therapies.

A major research project in her lab is investigations of glaucoma-associated herocilin, which has been funded by NIH since March 2011. Her lab has made major strides toward detailed molecular understanding of herocilin structure, function, and disease pathogenesis. They have divulged similarities between herocilin-associated glaucoma and other protein misfolding disorders, particularly aherloid diseases. Cumulatively, their work is leading to the first disease-modifying glaucoma therapeutic.

Lieberman also has a track record in membrane enzymes dating back to her thesis work where she solved the first crystal structure of the copper-dependent particulate methane monooxygenase. During her postdoc she shifted focus to intramembrane aspartyl proteases (IAPs), particularly those involved in neurodegenerative disease like Alzheimer’s disease. In her independent lab she developed new proteomics-based assays to measure IAP proteolysis. The lab also collaborates with physicists at Oak Ridge National Labs to use neutron scattering to probe structure and lipids in solution. This work has been funded by NSF and NIH.

She serves on the Executive Council of the Protein Society and as an academic editor for PLoS Biology. She also serves as co-PI of the Department of Education GAANN program in Biochemistry & Biophysics at Georgia Tech and on the advisory committees in a variety of capacities.

Professor
Phone
404-385-3663
Office
Petit Biotechnology Building, Office 1308
Additional Research
The Lieberman research group focuses on biophysical and structural characterization of proteins involved in misfolding disorders. One major research project in the lab has been investigations of the glaucoma-associated myocilin protein. The lab has made major strides toward detailed molecular understanding of myocilin structure, function, and disease pathogenesis. Our research has clearly demonstrated similarities between myocilin glaucoma and other protein misfolding disorders, particularly amyloid diseases. The work has led to new efforts aimed at amelioratingthe misfolding phenotype using chemical biology approaches. Our second project involves the study of membrane-spanning proteolytic enzymes, which have been implicated disorders such as Alzheimer disease. Our group is tackling questions surrounding discrimination among and presentation of transmembrane substrates as well as the enzymatic details of peptide hydrolysis. In addition to the biochemical characterization of intramembrane aspartyl proteases, our group is developing new crystallographic tools to improve the likelihood of determining structures of similarly challenging membrane proteins more generally.
IRI and Role
Bioengineering and Bioscience > Faculty
Bioengineering and Bioscience
University, College, and School/Department
Georgia Institute of Technology > College of Sciences > School of Chemistry & Biochemistry

Gabe Kwong

Gabe Kwong
gkwong@gatech.edu

Dr. Gabe Kwong is an Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Tech School of Engineering and Emory School of Medicine. His research program is conducted at the interface of the life sciences, medicine and engineering where a central focus is understanding how to harness the sophisticated defense mechanisms of immune cells to eradicate disease and provide protective immunity. Kwong has pioneered numerous biomedical technologies and published in leading scientific journals such as Nature Biotechnology and Nature Medicine. His work has been profiled broadly including coverage in The Economist, NPR, BBC, and WGBH-2, Boston 's PBS station. Professor Kwong earned his B.S. in Bioengineering with Highest Honors from the University of California, Berkeley and his Ph.D. in Bioengineering from California Institute of Technology with Professor James R. Heath. He conducted postdoctoral studies at Massachusetts Institute of Technology with Professor Sangeeta N. Bhatia. For his work, Dr. Kwong has been awarded the NIH Ruth L. Kirschstein National Research Service Award, named a "Future Leader in Cancer Research and Translational Medicine" by the Massachusetts General Hospital, and awarded the Burroughs Wellcome Fund Career Award at the Scientific Interface, a distinction given to the 10 most innovative bioengineers in the nation. Dr. Kwong holds seven issued or pending patents in cancer nanotechnology.

Associate Professor
Director, Laboratory for Synthetic Immunity
Phone
404-385-3746
Office
Marcus Nanotechnology 3132
Additional Research

Human health has been transformed by our collective capacity to engineer immunity — from the pivotal development of the smallpox vaccine to the curative potential of recent cancer immunotherapies. These examples motivate our research program that is conducted at the interface of Engineering and Immunology, and where we develop biomedical technologies and applications that shape a diverse array of immunological systems.The questions that are central to our exploration include: How do we begin to study an individual's repertoire of well over one billion immune cells when current technologies only allow us to study a handful of cells at a time? What are the biomarkers of immunological health as the body responds to disease and ageing, and how may these indicators trigger clinical decisions? And how can we genetically rewire immune cells to provide them with entirely new functions to better fight complex diseases such as cancer?To aid in our studies, we use high-throughput technologies such as next-generation sequencing and quantitative mass spectrometry, and pioneer the development of micro- and nanotechnologies in order to achieve our goals. We focus on clinical problems in cancer, infectious diseases and autoimmunity, and ultimately strive to translate key findings into therapies for patients.

IRI and Role
Bioengineering and Bioscience > Faculty
Bioengineering and Bioscience
Matter and Systems > Affiliated Faculty
University, College, and School/Department
Georgia Institute of Technology > College of Engineering > Coulter Department of Biomedical Engineering

Julia Kubanek

Julia Kubanek
julia.kubanek@biosci.gatech.edu

Julia Kubanek serves as Georgia Tech’s Vice President for Interdisciplinary Research and is a professor in the School of Biological Sciences and the School of Chemistry and Biochemistry. In this role, she oversees and supports interdisciplinary activities at Georgia Tech including the Interdisciplinary Research Institutes (IRIs); the Pediatric Technology Center (PTC), the Novelis Innovation Hub; the Center for Advanced Brain Imaging (CABI); and the Global Center for Medical Innovation (GCMI). She also partners across the institute on developing and advancing new research initiatives based on student and faculty interests, expertise, and societal need.

Kubanek has held several previous leadership roles at Georgia Tech, including Associate Dean for Research in the College of Sciences and Associate Chair in the School of Biological Sciences. She joined the faculty at Georgia Tech in 2001. Her areas of research interest include chemical signaling among organisms (especially in aquatic systems), natural products chemistry, metabolomics, chemical biology, and drug discovery. She has authored approximately 100 research articles on marine plankton and coral reef chemical ecology, and on the discovery, mechanism of action, and biosynthesis of marine natural products. She was awarded the NSF CAREER Award in 2002, the Presidential Early Career Award for Scientists and Engineers (PECASE) in 2004, and was elected Fellow of the American Association for the Advancement of Science (AAAS) in 2012. In 2016, she served as chair of the Gordon Research Conference in Marine Natural Products; since 2016, she has chaired the Scientific Advisory Board of the Max Planck Institute for Chemical Ecology. Kubanek received her B.Sc. in Chemistry from Queen’s University, Canada, in 1991 and her Ph.D. in at the University of British Columbia in 1998, and performed postdoctoral research at the University of California – San Diego and the University of North Carolina at Wilmington.

Professor
Vice President of Interdisciplinary Research
Phone
404-894-8424
Office
ES&T 2242
Additional Research
All organisms use chemicals to assess their environment and to communicate with others. Chemical cues for defense, mating, habitat selection, and food tracking are crucial, widespread, and structurally and functionally diverse. Yet our knowledge of chemical signaling is patchy, especially in marine environments. In our research we ask, "How do marine organisms use chemicals to solve critical problems of competition, disease, predation, and reproduction?" Our group uses an integrated approach to understand how chemical cues function in ecological interactions, working from molecular to community levels. We also use ecological insights to guide discovery of novel pharmaceuticals and molecular probes. In collaboration with other scientists, our most significant scientific achievements to date are: 1) characterizing the unusual molecular structures of antimicrobial defenses that protect algae from pathogens and which show promise to treat human disease; 2) understanding that competition among single-celled algae (phytoplankton) is mediated by a complex interplay of chemical cues that affect harmful algal bloom dynamics; 3) unraveling the molecular modes of action of antimalarial natural products towards developing new treatments for drug-resistant infectious disease; 4) discovering that progesterone signaling and quorum sensing are key pathways in the alternating sexual and asexual reproductive strategy of microscopic invertebrate rotifers - animals whose evolutionary history was previously thought to preclude either cooperative behavior (quorum sensing) typically associated with bacteria and hormonal regulation via progesterone typically seen in vertebrates; 5) identifying a novel aversivechemoreception pathway in predatory fish thatresults inrapid recognition and rejectionofchemically defended foods, thereby protecting these foods (prey) from predators. Ongoing projects include: 1) Waterborne chemical cues in the marine plankton: a systems biology approach (including metabolomics); 2) Exploration, conservation, and development of marine biodiversity in Fiji and the Solomon Islands (including drug discovery, mechanisms of action, and chemical ecology); 3) The role of sensory environment and predator chemical signal properties in determining non-consumptive effect strength in cascading interactions on oyster reefs; 4) Regulation of red tide toxicity by chemical cues from marine zooplankton; 5) Chemoreception of prey chemical defenses on tropical coral reefs.
IRI and Role
Bioengineering and Bioscience > Faculty
Data Engineering and Science > Faculty
Data Engineering and Science
Bioengineering and Bioscience
University, College, and School/Department
Georgia Institute of Technology > College of Sciences > School of Biological Sciences

YongTae (Tony) Kim

YongTae (Tony) Kim
yongtae.kim@me.gatech.edu

Kim joined the Woodruff School of Mechanical Engineering as an Assistant Professor in July 2013. Prior to his current appointment, he was a Postdoctoral Associate in the David H. Koch Institute for Integrative Cancer Research at MIT, where he developed biomimetic microsystems for probing nanoparticle behaviors in the inflamed endothelium and for synthesizing therapeutic and diagnostic nanomaterials. His doctorate research at CMU focused on closed-loop microfluidic control systems for lab-on-a-chip applications to biochemistry and developmental biology. Prior to his Ph.D., he was a researcher in areas of dynamics, controls, and robotics at R&D Divisions of Hyundai-Kia Motors and Samsung Electronics for six years.

Associate Professor, Woodruff School of Mechanical Engineering
Phone
404.385.1478
Office
Marcus 3134
Additional Research

Multifunctional Materials; Biosensors; Bio-MEMS; Tissue Engineering

IRI and Role
Bioengineering and Bioscience > Faculty
Bioengineering and Bioscience
Matter and Systems > Affiliated Faculty
University, College, and School/Department
Georgia Institute of Technology > College of Engineering > Woodruff School of Mechanical Engineering

Yonggang Ke

Yonggang Ke
yonggang.ke@emory.edu

Yonggang Ke's research is highly interdisciplinary combining chemistry, biology, physics, material science, and engineering. The overall mission of his research is to use interdisciplinary research tools to program nucleic-acid-based "beautiful structures and smart devices" at nanoscale, and use them for scientific exploration and technological applications. Specifically, his team focuses on (1) developing new DNA self-assembly paradigms for constructing DNA nanostructures with greater structural complexity, and with controllable sizes and shapes; (2) developing new imaging or drug delivery systems based on DNA nanostructuresl; (3) exploring design of novel DNA-based nanodevices for understanding basic biological questions at molecular level; (4) developing DNA-templated protein devices for constructing artificial bio-reactors.

For cancer-related research/application, Ke will focus on using DNA/RNA nanostructures as drug delivery vehicles. He is also interested in using DNA/RNA nanostructures to study cancer cell biology at molecular level.

Assistant Professor, Wallace H. Coulter Department of Biomedical Engineering
Phone
404.712.2712
Office
Emory HSRB E186
Additional Research

Molecular engineeringNucleic acid self-assemblyTargeted imaging and delivery

IRI and Role
Bioengineering and Bioscience > Faculty
Bioengineering and Bioscience
University, College, and School/Department
Georgia Institute of Technology > College of Engineering > Coulter Department of Biomedical Engineering

Ravi Kane

Ravi Kane
ravi.kane@chbe.gatech.edu

Ravi Kane is the Garry Betty/V Foundation Chair and GRA Eminent Scholar in Cancer Nanotechnology. He received a B.S. in Chemical Engineering from Stanford University in 1993. Also, he received an M.S. in Chemical Engineering Practice and a Ph.D. in Chemical Engineering from MIT, working with Bob Cohen and Bob Silbey. After postdoctoral research with George Whitesides in the Department of Chemistry and Chemical Biology at Harvard University, he joined Rensselaer Polytechnic Institute (RPI) as an assistant professor in 2001. He was promoted to associate professor in 2006, to full professor in 2007, and to the P.K. Lashmet Professor in 2008. He served as the head of RPI’s Howard P. Isermann Department of Chemical and Biological Engineering before moving to Georgia Tech in 2015. Prof. Kane has graduated 27 Ph.D students and contributed to over 130 scientific publications.

Professor
Garry Betty/V Foundation Chair
Georgia Research Alliance Eminent Scholar in Cancer Nanotechnology
Phone
404-385-4608
Office
EBB 5019
Additional Research
Professor Kane's groupconducts research at the interface of biotechnology and nanotechnology.The group is designing nanoscale polyvalent therapeutics and working on the molecular engineering of biosurfaces and nanostructures. A major focus of the group's research involves the design of polyvalent ligands, i.e., nanoscale scaffolds presenting multiple copies of selected biomolecules.The Kane group has made seminal contributions to a fundamental understanding of polyvalent recognition and has designed polyvalent inhibitors that are effectivein vivo.Currently, the group is designing polyvalent molecules that control stem cell fate as well as polyvalent inhibitors of pathogens such as HIV and influenza.The group is also designing nanoscale scaffolds for antigen presentation as part of novel strategies for designing vaccines.The approach could lead to the development of "universal" influenza vaccines as well as effective vaccines targeting RSV and malaria.Other interests of the group involve optogenetics — the development and application of methods that use light to control cell function — as well as the design of enzymes and nanocomposites that target antibiotic-resistant pathogens.
IRI and Role
Bioengineering and Bioscience > Faculty
Bioengineering and Bioscience
University, College, and School/Department
Georgia Institute of Technology > College of Engineering > School of Chemical and Biomolecular Engineering

Seung Soon Jang

Seung Soon Jang
SeungSoon@mse.gatech.edu

Seung Soon Jang joined the School of Materials Science and Engineering at the Georgia Institute of Technology in July 2007. Jang worked at Samsung Electronics and the Materials and Process Simulation Center (MSC) at CalTech performing various researches in nanoelectronics, fuel cell, and interfacial systems as a director of Supramolecular Technology for six years.

His research interest includes computations and theories to characterize and design nanoscale systems based on the molecular architecture-property relationship, which are especially relevant to molecular electronics, molecular machines, fuel cell technology and biotechnology.

Professor, School of Materials Science and Engineering
Director, Computational NanoBio Technology Lab
Phone
404.385.3356
Office
Love 351
Additional Research

Jang's research interest is to characterize and design nanoscale systems based on the molecular architecture-property relationship using computations and theories, which are especially relevant to designing new biomaterials for drug delivery and tissue engineering. Currently, he is focusing on 1) NanoBio-mechanics for DNA, lipid bilayer, and hydrogel systems; 2) Molecular interaction of Alzheimer proteins with various small molecules. Dr. Jang is also interested in various topics such as nanoelectronics, nanostructured energy technologies for fuel cell, battery and photovoltaic devices.;Computational mechanics; Nanostructured Materials; Polymeric composites; Biomaterials; Fuel Cells; Delivery and Storage

IRI and Role
Bioengineering and Bioscience > Faculty
Energy > Hydrogen Group
Energy > Research Community
Bioengineering and Bioscience
Energy
University, College, and School/Department
Georgia Institute of Technology > College of Engineering > School of Materials Science Engineering

Karl Jacob

Karl Jacob
karl.jacob@mse.gatech.edu

Karl I. Jacob, a professor of Materials Science and Engineering with a joint appointment in the G. W. Woodruff School of Mechanical Engineering, teaches graduate and undergraduate courses on polymer physics and engineering, rheology, and mechanics of polymeric materials. His graduate work was in the area of numerical analysis of vibrating three-dimensional structures. He came to Georgia Tech from DuPont Corporation in 1995. His initial work at the DuPont Dacron Research Laboratory was in the area of fiber-reinforced composite materials and in the development and modeling of fiber spinning processes. He then moved to the DuPont Central Research and Development Department, where he was involved in molecular modeling, computational chemistry, and diffusion.

Jacob is a member of the American Academy of Mechanics, the American Society of Mechanical Engineers, the Sigma Xi Research Society, and the Phi Kappa Phi Honor Society.

Professor, School of Materials Science and Engineering and School of Mechanical Engineering
Phone
404.894.2541
Office
MRDC-1 4509
Additional Research

"Dr. Jacob's research is directed at stress induced phase changes, nanoscale characterization of materials, synthesis of polymeric nanofibers, mechanical behavior of fiber assemblies (particularly related to biological systems and biomimitic systems), nanoparticle reinforced composites, transdermal drug delivery systems, large scale deformation of rubbery (networked) polymers, and nanoscale fracture of materials. The objectives in this work, using theoretical, computational and experimental techniques, is to understand the effect of micro- and nano- structures in the behavior of materials in order to try to design the micro/nano structures for specific materials response. Dr. Jacob plans are to continue current research interests with a multidisciplinary thrust with more emphasis in bio related areas and to start some work on the dynamic behavior of materials and structures. Graduate students could benefit from the interdisciplinary nature of the work combining classical continuum mechanics with nanoscale analysis for various applications, particularly in the nano and bio areas. Dr. Jacob has extensive experience in vibrations and stability of structures, mechanics of polymeric materials, behavior of fiber assemblies, stress-induced phase transformation, diffusion, and molecular modeling. His research involves the application of mechanics principles, both theoretical and experimental, in the analysis and design of materials for various applications.";Fibers; smart textiles; fuel cells; Polymeric composites

IRI and Role
Bioengineering and Bioscience > Faculty
Renewable Bioproducts > Faculty
People and Technology
Bioengineering and Bioscience
Renewable Bioproducts
University, College, and School/Department
Georgia Institute of Technology > College of Engineering